UBS Downgrades CME Group (CME) Amid Trading Headwinds

CME Group Inc. (NASDAQ:CME) is one of the best performing crypto stocks so far in 2025. On July 24, UBS downgraded CME Group stock from “Buy” to “Neutral” and maintained its price target at $305. Analyst Alex Kramm stated that the downgrade is due to “tough comps ahead.”

UBS Downgrades CME Group (CME) Amid Trading Headwinds

UBS also cited a recent slowdown in trading activity as a primary reason for the downgrade. “Geopolitical uncertainty has helped drive volumes and the stock higher over the past year, but activity has started to slow recently, down 13% year-over-year in June so far, while comps are getting tougher,” stated Kramm.

Despite acknowledging structural growth drivers like increased retail trading, UBS expressed skepticism about significant short-term gains. The bank also reduced its earnings projections, forecasting earnings per share (EPS) for Q3 2025 at 9% below consensus estimates and 2% below for the full fiscal year 2025.

CME Group Inc. (NASDAQ:CME) is a global derivatives marketplace. It offers regulated cryptocurrency futures and options contracts, including products tied to Bitcoin, Ether, Solana, and XRP. The company also provides standardized reference rates and real-time indices for over 20 cryptocurrencies through its partnership with CF Benchmarks. CME Group’s primary crypto-related services include trading, clearing, and data solutions for institutional clients seeking exposure to digital assets.

READ NEXT: 10 Best Alternative Meat Stocks to Invest In According to Analysts and Top 10 AI Stocks With Huge Upside Potential.

Disclosure: None. This article is originally published at Insider Monkey.